Cystic fibrosis and other ion channel-related diseases
作者
Simon Y. Graeber,Marcus Alexander Mall
出处
期刊:European Respiratory Society eBooks [European Respiratory Society] 日期:2023-06-01被引量:2
标识
DOI:10.1183/2312508x.10018022
摘要
Cystic fibrosis (CF) is the most common severe genetic disorder in Caucasian populations and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes an epithelial chloride channel. Although CF is a multisystem disease affecting many epithelial organs including the lungs, pancreas and intestine, chronic lung disease remains the major cause of morbidity and mortality. In the airways, CFTR dysfunction results in reduced airway surface liquid and impaired mucociliary clearance leading to muco-obstructive lung disease. Recently developed CFTR modulators restore CFTR function effectively in up to 90% of patients with the common F508del-CFTR mutation. Mutation-agnostic approaches such as gene therapy or targeting of alternative ion channels involved in airway surface hydration are currently under investigation. Beyond CF, other ion channels may be implicated in the pathogenesis of chronic airways disease and emerging evidence suggests a role of acquired CFTR dysfunction in COPD, suggesting that therapies developed for CF may also be beneficial for a spectrum of other muco-obstructive lung diseases. Cite as: Graeber SY, Mall MA. Cystic fibrosis and other ion channel-related diseases. In: Wagner TOF, Humbert M, Wijsenbeek M, et al., eds. Rare Diseases of the Respiratory System (ERS Monograph). Sheffield, European Respiratory Society, 2023; pp. 135–149 [ https://doi.org/10.1183/2312508X.10018022 ].